| 2026-03-17 | Dr. Yu-Waye ChuSenior VP & Chief Medical Officer | -21,28k | 136,68k | Verkauf | 6,42 | 39,61k | -34,95% |
| 2026-03-17 | Dr. Sean A. McCarthyChairman & CEO | -118,97k | 764,14k | Verkauf | 6,42 | 714,58k | -14,27% |
| 2026-03-17 | Dr. Marcia P. BelvinSenior VP & Chief Scientific Officer | -31,49k | 202,27k | Verkauf | 6,42 | 164,93k | -16,03% |
| 2026-03-17 | Mr. Christopher W. OgdenSVP, CFO & Secretary | -19,32k | 124,11k | Verkauf | 6,42 | 123,87k | -13,49% |
| 2025-11-06 | Dr. Sean A. McCarthyChairman & CEO | -101,79k | 461,91k | Automatic Disposition | 4,54 | 592,30k | -14,67% |
| 2025-06-13 | Mr. Christopher W. OgdenSVP, CFO & Secretary | 26,89k | 0,00 | Derivative Exercise and Retained Stock | - | 76,28k | 54,43% |
| 2025-06-13 | Mr. Christopher W. OgdenSVP, CFO & Secretary | -10,61k | 28,54k | Derivative Exercise and Sale | 2,69 | 76,28k | - |
| 2025-06-13 | Mr. Christopher W. OgdenSVP, CFO & Secretary | -1,64k | 4,84k | Verkauf | 2,95 | 76,28k | -2,11% |
| 2025-06-13 | Dr. Marcia P. BelvinSenior VP & Chief Scientific Officer | 23,62k | 0,00 | Derivative Exercise and Retained Stock | - | 113,29k | 26,33% |
| 2025-06-13 | Dr. Marcia P. BelvinSenior VP & Chief Scientific Officer | -13,88k | 37,33k | Derivative Exercise and Sale | 2,69 | 113,29k | - |
| 2025-06-13 | Dr. Sean A. McCarthyChairman & CEO | 94,49k | 0,00 | Derivative Exercise and Retained Stock | - | 694,09k | 15,76% |
| 2025-06-13 | Dr. Sean A. McCarthyChairman & CEO | -55,51k | 149,26k | Derivative Exercise and Sale | 2,69 | 694,09k | - |